Today: 11 June 2026
CoreWeave stock rises as Wells Fargo trims target and insiders signal sales
8 January 2026
1 min read

CoreWeave stock rises as Wells Fargo trims target and insiders signal sales

NEW YORK, Jan 8, 2026, 13:07 EST — Regular session

  • CoreWeave shares up 1.6% at $78.43 in midday Nasdaq trade
  • Wells Fargo keeps a buy call, cuts target price to $125 from $150
  • Truist starts coverage at Hold; a Form 144 shows CEO Michael Intrator planning a share sale

CoreWeave shares rose 1.6% to $78.43 on Thursday, after Wells Fargo cut its price target on the AI cloud firm while keeping a buy-equivalent rating. The stock ranged between $76.03 and $79.92.

The calls land at a moment when investors are trying to pin down what “AI infrastructure” is worth once you strip out the excitement and look at debt, buildout timing and cash needs. CoreWeave’s shares have swung sharply in recent months, including after the company previously warned of revenue pressure tied to delays in bringing data centers online. Reuters

CoreWeave runs a cloud platform built for artificial intelligence workloads, leaning heavily on fleets of Nvidia chips. The Livingston, New Jersey-based company has billed itself as a specialist provider as big tech and AI labs race to secure compute.

Truist Securities this week initiated coverage with a Hold rating and an $84 price target, calling the risk-reward “balanced” given leverage and the spending needed to keep adding capacity. Analyst Arvind Ramnani pointed to CoreWeave’s rapid growth, but flagged the cost of feeding that growth. Investing.com

A separate pressure point is insider selling. A Form 144 filed on Jan. 6 showed Chief Executive Officer Michael Intrator planned to sell 61,386 shares, with an estimated market value of about $4.7 million, through Morgan Stanley Smith Barney; Form 144 is a notice required when an insider plans to sell stock under SEC Rule 144. The form also referenced a Rule 10b5-1 plan — a pre-set trading plan — and included a standard representation that the seller “does not know any material adverse information” that has not been publicly disclosed.

On Wall Street, the targets remain scattered even as firms circle similar themes. Analysts polled by FactSet rate the stock “Overweight” on average, with a mean target price around $123.54, MT Newswires reported. Futu News

CoreWeave’s story is also tied to Nvidia’s supply chain. Reuters has reported Nvidia signed a multi-billion-dollar cloud capacity order with CoreWeave and agreed to buy back unused capacity through 2032, a backstop investors watch when the debate turns to utilization and returns.

But the stock’s swings have made it a proxy for a broader question: how much debt the market will tolerate in exchange for growth, and how fast builders can bring power and data centers online. Any fresh signs of tighter financing or slower AI spending can hit these names quickly.

Next up, traders will watch Friday’s U.S. employment report (8:30 a.m. ET) for its knock-on effect on rate expectations and high-growth valuations, with the Federal Reserve’s Jan. 27-28 policy meeting also looming. For CoreWeave-specific catalysts, Nasdaq’s earnings calendar lists Feb. 9 as the expected next report date, though schedules can change.

Stock Market Today

  • Fannie Mae (OTCPK:FNMA) Shares Dive 21% Amid Valuation Debate
    June 11, 2026, 10:38 AM EDT. Fannie Mae (FNMA) shares dropped about 21% in the past month, raising investor questions on valuation. Despite the pullback, FNMA boasts a 44% year-to-date decline but a strong 171% gain over five years. The perceived undervaluation, with a fair value estimate of $12.08 versus a last close near $6.17, hinges on optimistic long-term housing finance assumptions. FNMA's $4.1 trillion mortgage guaranty book and rising guaranty fees could support earnings growth. However, risks include weaker mortgage volumes and increasing credit stress in the multifamily segment. Investors are advised to weigh these factors carefully and consider other finance and housing stocks before investing.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Broadcom stock (AVGO) slides as Nvidia’s China chip payment demand ripples through AI semiconductors
Previous Story

Broadcom stock (AVGO) slides as Nvidia’s China chip payment demand ripples through AI semiconductors

Leonardo DRS stock pops 8% as Trump’s $1.5 trillion defense budget call lifts contractors
Next Story

Leonardo DRS stock pops 8% as Trump’s $1.5 trillion defense budget call lifts contractors

Go toTop